Lumbar Interbody Implant Study

ClinicalTrials.gov ID: NCT04418830

Public ClinicalTrials.gov record NCT04418830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter Study Evaluating the Safety and Performance of Interbody Implants for the Treatment of Patients With Degenerative Conditions of the Thoracic and/or Lumbar Spine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the safety and performance of NuVasive interbody implants when used during thoracic and/or lumbar spine surgery as measured by reported complications, radiographic outcomes, and patient-reported outcomes. This study is being undertaken to identify possible residual risks and to clarify mid- to long-term clinical performance that may affect the benefit/risk ratios of these interbody implants.

Study identification

NCT ID: NCT04418830
Recruitment status: Enrolling by invitation
Study type: Observational
Phase: Not listed
Lead sponsor: NuVasive; Industry
Enrollment: 1,050 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 1, 2020 (Actual)
Primary completion: Dec 31, 2025 (Estimated)
Completion: Jul 1, 2026 (Estimated)
Last update posted: Dec 22, 2025

2020 – 2026

United States locations

U.S. sites: 16
U.S. states: 10
U.S. cities: 16

Facility	City	State	ZIP	Site status
University of California San Diego	La Jolla	California	92037	—
Verma Spine	Los Alamitos	California	90720	—
Valley Spine Care	Merced	California	95348	—
Hoag Orthopedics	Orange	California	92868	—
Hartford Healthcare Bone and Joint Institute	Hartford	Connecticut	06106	—
Lyerly Neurosurgery	Jacksonville	Florida	32207	—
Northwestern University	Chicago	Illinois	60610	—
DuPage Medical Group	Naperville	Illinois	60540	—
Beaumont Hospital Research Institute	Royal Oak	Michigan	48073	—
Columbia Orthopaedics Group	Columbia	Missouri	65201	—
Duke University	Durham	North Carolina	27710	—
Atlantic Brain and Spine	Wilmington	North Carolina	28401	—
Summa Health	Akron	Ohio	44320	—
Ohio State University	Dublin	Ohio	43016	—
UPMC Presbyterian	Pittsburgh	Pennsylvania	15213	—
University of Virginia	Charlottesville	Virginia	22908	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04418830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 22, 2025 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04418830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →